Full-Time
Posted on 9/2/2025
Clinically validated hormone optimization and treatment
No salary listed
Birmingham, AL, USA
In Person
Candidates must also be licensed in AL, AR, CA, FL, ID, KY, LA, MD, MI, MS, NE, OK, OR, TN, TX, VA, WV or be willing to test/exam and or reciprocate licensure according to individual state requirements.
Biote focuses on hormone optimization using clinically validated medical approaches to identify and treat imbalances in hormone production. It uses lab testing and medical assessment to pinpoint hormone deficiencies or excesses, then prescribes personalized treatment plans—often including bio-identical hormone therapy and related regimens—under medical supervision to restore balanced hormone levels. Biote differentiates itself through its emphasis on translating extensive scientific insight (80+ years of research) into validated protocols and continuing medical oversight, rather than generic supplements. The company’s goal is to help patients achieve balanced hormone levels and improve health outcomes by delivering scientifically grounded, physician-guided hormone optimization.
Company Size
201-500
Company Stage
IPO
Headquarters
Irving, Texas
Founded
2012
Help us improve and share your feedback! Did you find this helpful?
Health Insurance
Dental Insurance
Vision Insurance
Life Insurance
401(k) Company Match
401(k) Retirement Plan
Paid Vacation
Paid Holidays
Paid Time Off
Hemingway Medical Spa Inc. partnered with Biote because they share its commitment to improving the quality of patients lives through a more natural and less pharmacologic approach.
Hampton Roads Orthopaedics and Sports Medicine has chosen Biote as its partner for hormone replacement therapy due to their proven track record and commitment to excellence.
Irving-based Biote Corp. announced that it will acquire Asteria Health, a privately held manufacturer of compounded bioidentical hormones, in a deal valued at $8.5 million.
biote Corp. (NASDAQ: BTMD) (“Biote” or the “Company”), a leading solutions provider in preventive health care through the delivery of personalized hor
biote Corp., a leading solutions provider in preventive health care through the delivery of personalized hormone optimization and therapeutic wellness, announced that Robert Peterson has been named Chief Financial Officer, effective January 8, 2024.